DFEMX
Price
$30.12
Change
-$0.05 (-0.17%)
Updated
Feb 21 closing price
Net Assets
5.36B
VEIEX
Price
$29.29
Change
+$0.04 (+0.14%)
Updated
Feb 21 closing price
Net Assets
109.55B
Ad is loading...

DFEMX vs VEIEX

Header iconDFEMX vs VEIEX Comparison
Open Charts DFEMX vs VEIEXBanner chart's image
DFA Emerging Markets I
Price$30.12
Change-$0.05 (-0.17%)
VolumeN/A
Net Assets5.36B
Vanguard Emerging Mkts Stock Idx I
Price$29.29
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets109.55B
DFEMX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFEMX vs. VEIEX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFEMX is a Buy and VEIEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 110B vs. DFEMX (5.36B). DFEMX (3.32) and VEIEX (3.27) have matching dividends . DFEMX was incepted earlier than VEIEX: DFEMX (31 years) vs VEIEX (31 years). DFEMX (0) and VEIEX (0) have matching initial minimum investment requirements. VEIEX annual gain was more profitable for investors over the last year : 13.41 vs. DFEMX (11.13). DFEMX return over 5 years is better than : 19.90 vs. VEIEX (17.33).
DFEMXVEIEXDFEMX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years31 years-
Gain YTD5.4254.532120%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.36B110B5%
Annual Yield % from dividends3.323.27102%
Returns for 1 year11.1313.4183%
Returns for 3 years3.851.75220%
Returns for 5 years19.9017.33115%
Returns for 10 years33.5930.30111%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHG25.550.52
+2.08%
Koninklijke Philips NV
PDM7.07-0.07
-1.05%
Piedmont Office Realty Trust
KTB87.93-1.60
-1.79%
Kontoor Brands
RCKY23.09-0.79
-3.31%
Rocky Brands
BCTX4.42-0.65
-12.82%
Briacell Therapeutics Corp NEW